ITEM VIEW

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line Stavudine-containing antiretroviral therapy: Programmatic implications for countries phasing out Stavudine

dc.contributor.authorTang MW
dc.contributor.authorRhee S-Y
dc.contributor.authorBertagnolio S
dc.contributor.authorFord N
dc.contributor.authorHolmes S
dc.contributor.authorSigaloff KC
dc.contributor.authorHamers RL
dc.contributor.authorde Wit TFR
dc.contributor.authorFleury HJ
dc.contributor.authorKanki PJ
dc.contributor.authorRuxrungtham K
dc.contributor.authorHawkins CA
dc.contributor.authorWallis C
dc.contributor.authorStevens WS
dc.contributor.authorVan Zyl GU
dc.contributor.authorET AL
dc.date.accessioned2014-07-07T12:26:28Z
dc.date.available2014-07-07T12:26:28Z
dc.date.issued2013
dc.identifier.citationJournal of Infectious Diseases
dc.identifier.citation207
dc.identifier.urihttp://hdl.handle.net/10019.1/93544
dc.descriptionPlease help populate SUNScholar with the full text of SU research output. Also - should you need this item urgently, please send us the details and we will try to get hold of the full text as quick possible. E-mail to scholar@sun.ac.za. Thank you.
dc.descriptionJournal Articles (subsidised)
dc.descriptionGeneeskunde en Gesondheidswetenskappe
dc.descriptionGeneeskundige Virologie
dc.publisherUNIV CHICAGO PRESS, 1427 E 60TH ST, CHICAGO, USA, IL, 60637-2954
dc.titleNucleoside reverse transcriptase inhibitor resistance mutations associated with first-line Stavudine-containing antiretroviral therapy: Programmatic implications for countries phasing out Stavudine


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

ITEM VIEW